APA

Sultan A. A., Jerjes W., Berg K., Høgset A., Mosse C. A., Hamoudi R., Hamdoon Z., Simeon C., Carnell D., Forster M. & Hopper C. (20170605). Disulfonated tetraphenyl chlorin (TPCS2a)-induced photochemical internalisation of bleomycin in patients with solid malignancies: a phase 1, dose-escalation, first-in-man trial. : The Lancet. Oncology.

Chicago

Sultan Ahmed A, Jerjes Waseem, Berg Kristian, Høgset Anders, Mosse Charles A, Hamoudi Rifat, Hamdoon Zaid, Simeon Celia, Carnell Dawn, Forster Martin and Hopper Colin. 20170605. Disulfonated tetraphenyl chlorin (TPCS2a)-induced photochemical internalisation of bleomycin in patients with solid malignancies: a phase 1, dose-escalation, first-in-man trial. : The Lancet. Oncology.

Harvard

Sultan A. A., Jerjes W., Berg K., Høgset A., Mosse C. A., Hamoudi R., Hamdoon Z., Simeon C., Carnell D., Forster M. and Hopper C. (20170605). Disulfonated tetraphenyl chlorin (TPCS2a)-induced photochemical internalisation of bleomycin in patients with solid malignancies: a phase 1, dose-escalation, first-in-man trial. : The Lancet. Oncology.

MLA

Sultan Ahmed A, Jerjes Waseem, Berg Kristian, Høgset Anders, Mosse Charles A, Hamoudi Rifat, Hamdoon Zaid, Simeon Celia, Carnell Dawn, Forster Martin and Hopper Colin. Disulfonated tetraphenyl chlorin (TPCS2a)-induced photochemical internalisation of bleomycin in patients with solid malignancies: a phase 1, dose-escalation, first-in-man trial. : The Lancet. Oncology. 20170605.